ELAB vs SPG · rev $2.0M vs rev $3.55B
Elevai Labs, Inc. Common Stock (ELAB) versus SPG (SPG) — a side-by-side from cached financials, not a winner call.
Elevai Labs, Inc. Common Stock (ELAB) is a biotechnology company listed on NASDAQ.
SPG (SPG) common stock.
Latest reported ELAB revenue for 2026-06-30 was $2.0M. Net income was -$7.9M. ELAB currently screens at market cap $6.5M.
Latest reported SPG revenue for 2026-06-30 was $3.55B. Net income was $1.14B. SPG currently screens at market cap $0.
ELAB currently screens at market cap $6.5M. SPG currently screens at market cap $0.
Not investment advice. Open the ELAB and SPG stock pages for the full models.
Not investment advice.